Skip to main content

Biometry

Contributes to the rigor and reproducibility of cancer research through statistical consultation and mathematical modeling. Supports research in biostatistical methods and data analytics, machine learning, and artificial intelligence for cancer risk prediction and reduction.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Resources

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Berger, Vance, Ph.D. vance.berger@nih.gov 240-276-7142	5E628	Statistician \| Biometry
	Bowles, Heather, Ph.D. heather.bowles@nih.gov 240-276-6794	5E640	Program Officer \| Biometry Cancer Prevention Fellowship Program
	Dodd, Kevin, Ph.D. kevin_dodd@nih.gov 240-276-7021	5E126	Deputy Chief \| Biometry
	Hu, Ping, Sc.D. ping.hu@nih.gov 240-276-7015	5E118	Statistician \| Biometry
	Morris, Lawrence lawrence.morris@nih.gov 240-276-7137	5E112	Program Specialist \| Biometry
	Prorok, Philip C, Ph.D. [C] philip.prorok@nih.gov 240-276-7131		Contractor \| Office of the Director Biometry
	Sirota, Lev, Ph.D. [C] lev.sirota@nih.gov 240-276-5127	5E114	Contractor \| Biometry
	Uzzell, Norwood norwood.uzzell@nih.gov 240-276-7141	5E222	Program Support Assistant \| Biometry
	Xu, Jian-Lun, Ph.D. jian-lun.xu@nih.gov 240-276-7023	5E128	Statistician \| Biometry

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Judge, Andrew Robert	University Of Florida United States	The Complement System and Cancer Cachexia	5R01AR081648-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	1R21CA296671-01	Matthew Young, Ph.D.
Kachnic, Lisa A.	Columbia University Health Sciences United States	Columbia University NCI Community Oncology Research Program	3UG1CA189960-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kahalley, Lisa Schum	Baylor College Of Medicine United States	Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.	3R01CA249988-05S3	Rachel Altshuler, Ph.D.
Kalpathy-Cramer, Jayashree	University Of Colorado Denver United States	AI algorithm development for cervical cancer screening in low resource settings	1R21CA305472-01	Nicholas Hodges, Ph.D.
Kanarek, Naama	Boston Children'S Hospital United States	Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF	5R01CA282477-02	John Clifford, Ph.D.
Kanetsky, Peter A	H. Lee Moffitt Cancer Ctr & Res Inst United States	A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers	5R01CA291735-02	Claire Zhu, Ph.D.
Kang, Dongkyun	University Of Arizona United States	Non-invasive, quantitative microscopic biomarkers for chemotherapy-induced peripheral neuropathy	1R01CA301271-01	Rachel Altshuler, Ph.D.
Kanwal, Fasiha	Baylor College Of Medicine United States	Risk Stratification for and Early Detection of Liver Cancer	5U01CA230997-08	Sidney Fu, M.D.
Kassie, Fekadu	University Of Minnesota United States	Targeting tumor cell mitochondria for the prevention and treatment of lung cancer	1R01CA285608-01A1
Kelleher, Sarah	Duke University United States	Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings	5R21CA273832-02	Brennan Streck, Ph.D., RN, M.P.H.
Kelleher, Sarah	Duke University United States	Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients	5R01CA291888-02	Brennan Streck, Ph.D., RN, M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Determinants of transdermal drug delivery to the normal and the radiated breast	5R01CA235647-05	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Northwestern Cancer Prevention Consortium	2UG1CA242643-07	Donald Johnsey
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-05	Rachel Altshuler, Ph.D.